Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Biomarkers for the Early Detection of Mesothelioma

NCT04106973 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04106973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04106973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Biomarkers for the Early Detection of Mesothelioma
Lead sponsor
Henry Ford Health System
Phase
Observational
Overall status
Terminated
Start date
June 5, 2019
Completion date
January 1, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asbestos exposure, pleural mesothelioma, pleural plaque